Bacitracin Zinc And Polymyxin B Sulfate
Product Images NDC 53002-9271

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bacitracin Zinc And Polymyxin B Sulfate (NDC 53002-9271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bacitracin A (strucural Formula) (5cfad642 E7d0 4451 8bd4 29665208ac8d 01)

Chemical structure diagram of Bacitracin A showing its amino acid sequence and molecular connections. The illustration details the peptide chain with labeled amino acid residues and chemical groups relevant to Bacitracin's composition.*

FDA Label Image

Polymyxin B Sulfate (structural Formula) (5cfad642 E7d0 4451 8bd4 29665208ac8d 02)

Chemical structure of Polymyxin B Sulfate showing the molecular arrangement of its components, including L-DAB residues and the methylheptyl group. The formula also indicates the association with sulfuric acid (xH2SO4).*

FDA Label Image

Label Image (Lbl530029271)

Packaging label for Bacitracin Zinc and Polymyxin B Sulfate ophthalmic ointment, 3.5 grams, by RPK Pharmaceuticals, Inc. The label instructs application to affected eye(s) 4 times a day or as directed. It includes NDC 53002-9271 and space for clinic name and prescription information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.